APA (7th ed.) Citation

Calzetta, L., Cazzola, M., Gholamalishahi, S., & Rogliani, P. The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement. Elsevier.

Chicago Style (17th ed.) Citation

Calzetta, Luigino, Mario Cazzola, Shima Gholamalishahi, and Paola Rogliani. The Novel Inhaled Dual PDE3 and PDE4 Inhibitor Ensifentrine for the Treatment of COPD: A Systematic Review and Meta-analysis Protocol on Trough FEV1 and Exacerbation According to PRISMA Statement. Elsevier.

MLA (9th ed.) Citation

Calzetta, Luigino, et al. The Novel Inhaled Dual PDE3 and PDE4 Inhibitor Ensifentrine for the Treatment of COPD: A Systematic Review and Meta-analysis Protocol on Trough FEV1 and Exacerbation According to PRISMA Statement. Elsevier.